Low-Income HIV Patients Should Have Access To Below Medicaid Rx Prices, IoM Says
This article was originally published in The Pink Sheet Daily
Executive Summary
An Institute of Medicine report estimates that a proposed new federally-funded program could save up to 25% off Medicaid prices for antiretroviral drugs by applying the Federal Ceiling Price or the Federal Supply Schedule price.